Trademark: 90658699
Status Date
Tuesday, February 6, 2024
Filing Date
Tuesday, April 20, 2021
Published for Opposition
Tuesday, July 19, 2022
5 pharmaceuticals for the treatment, diagnosis or prophylaxis of human diseases, disorders and conditions, namely, cancer, and diseases, disorders and conditions of the hematological systems
Feb 8, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 6, 2024
Sou Extension 3 Granted
Feb 6, 2024
Sou Extension 3 Filed
Feb 6, 2024
Sou Teas Extension Received
Aug 10, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 8, 2023
Sou Extension 2 Granted
Aug 8, 2023
Sou Extension 2 Filed
Aug 8, 2023
Sou Teas Extension Received
Mar 9, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 7, 2023
Sou Extension 1 Granted
Mar 7, 2023
Sou Extension 1 Filed
Mar 7, 2023
Sou Teas Extension Received
Feb 15, 2023
Teas Change Of Correspondence Received
Feb 15, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 15, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 13, 2022
Noa E-Mailed - Sou Required From Applicant
Jul 19, 2022
Official Gazette Publication Confirmation E-Mailed
Jul 19, 2022
Published For Opposition
Jun 29, 2022
Notification Of Notice Of Publication E-Mailed
Jun 16, 2022
Approved For Pub - Principal Register
Jun 10, 2022
Teas/Email Correspondence Entered
Jun 10, 2022
Correspondence Received In Law Office
Jun 10, 2022
Teas Response To Office Action Received
Dec 13, 2021
Notification Of Non-Final Action E-Mailed
Dec 13, 2021
Non-Final Action E-Mailed
Dec 13, 2021
Non-Final Action Written
Dec 13, 2021
Assigned To Examiner
Jul 28, 2021
New Application Office Supplied Data Entered
Apr 23, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
